Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2000

Insertion/deletion polymorphism in the angiotensin-converting enzyme gene inmyocardial infarction survivors.

Jaroslav A. Hubacek, Jan Pitha, Ivana Podrapská, Jan Sochman, Vera Adámková, Vera Lánská, Rudolf Poledne

Med Sci Monit 2000; 6(3): CR503-506 :: ID: 421318

Abstract

INTRODUCTION: Insertion/deletion (I/D) polymorphism of the angiotensin-convertingenzyme (ACE) gene influenced the plasma concentration of the ACE, and is D allele have been repetitivelysuggested as a risk factor for myocardial infarction (MI). MATERIAL AND METHODS: Two hundert thirty sixmale myocardial infarction survivors under 65 years and with body mass index and total plasma cholesterollevels under 95% of the Czech population were included in the study. As control group, 302 male controls(1% randomly selected group from the Czech population) were genotyped. I/D polymorphism in the ACE genewas determined using polymerase chain reaction. RESULTS: The prevalence of the I/I, I/D and D/D genotypeswas 0.218, 0.494 and 0.288, in the control group, and 0.178, 0.538 and 0.284, in the myocardial survivors,respectively. The male Czech population has the similar frequency of insertion and deletion alleles comparedto other Caucasian populations. The frequencies of the alleles and genotypes of the ACE gene did notdiffer significantly between MI survivors and a control sample of the Czech population. CONCLUSION: Itwas shown that the I/D polymorphism in the gene for ACE is not a genetic risk factor for myocardial infarctionin the Czech population.

Keywords: Blood Pressure, Body Mass Index, Cholesterol, Comparative Study, Czech Republic, DNA Transposable Elements, Gene Deletion, Genotype, Lipoproteins, HDL Cholesterol, Lipoproteins, LDL Cholesterol, Peptidyl-Dipeptidase A, Polymorphism, Genetic, Reference Values, Research Support, Non-U.S. Gov, Survivors, Triglycerides

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750